好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Rheumatoid Meningitis with Elevated Cyclic Citrullinated Peptide Antibodies and No Evidence of Arthritic Disease
Autoimmune Neurology
P1 - Poster Session 1 (5:30 PM-6:30 PM)
15-028
NA

Rheumatoid meningitis (RM) is a rare but serious complication of rheumatoid arthritis (RA) that affects the central nervous system (CNS) with varied symptomatology. RM has been reported to occur independent of active synovial disease or history of RA, and may serve as the initial presentation of subsequent disease. CSF studies can be normal or show a lymphocytic pleocytosis. Serum RA biomarkers, rheumatoid factor (RF) and anti-cyclic citrullinated peptide (CCP), can support the diagnosis of RM however they alone are not diagnostic. MRI commonly shows meningeal thickening and enhancement with possible T2 changes within the subarachnoid space. Diagnosis is confirmed with biopsy. Here we present a case of RM in a woman without history or development of RA.

A 72 year old woman with a history of hypertension and peripheral vascular disease developed stroke-like symptoms, epilepsy, and psychiatric decompensation over a 6 month period. Initial presentation included resolving left facial weakness, dysarthria, and left sided hemiplegia. She developed focal motor seizures one month later. Initial diagnosis of stroke with subsequent focal epilepsy was made, however following transfer to tertiary care center this diagnosis was questioned and evaluated further.

CSF profile was significant only for a WBC of 12 with lymphocytic predominance. Serum studies showed a highly elevated anti-CCP of 197.5 (reference 0-19 units). RF was negative. Review of previous MR images revealed progressive intrahemispheric meningeal thickening with subarachnoid signal intensity previously interpreted as ischemic changes. Dural biopsy ultimately revealed necrotizing granulomatous inflammation. Extensive infectious workup was unrevealing. She was treated with corticosteroids and cyclophosphamide with clinical improvement, and MR imaging demonstrated resolution of abnormal meningeal signal. Now one year later she continues to have no evidence of systemic rheumatoid disease.

In cases of idiopathic aseptic inflammatory meningitis evaluation for rheumatoid meningitis with serum testing for anti-CCP should be considered.
Authors/Disclosures
Deja Rose, MD
PRESENTER
Dr. Rose has nothing to disclose.
No disclosure on file
Matthew Berk, MD (Thomas Jefferson University) Dr. Berk has nothing to disclose.